ANTHEM quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Anthem Biosciences Ltd reported sales of ₹594 Cr, operating profit of ₹271 Cr (OPM 46%) and net profit of ₹211 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
ANTHEM quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
498
483
540
550
423
611
418
594
YoY Sales growth
-
-
60
5
-15
26
-23
8
Expenses
338
288
349
332
266
344
268
323
Operating Profit
160
195
191
218
157
267
151
271
OPM
32%
40%
35%
40%
37%
44%
36%
46%
Other Income
24
14
23
48
8
52
25
59
Interest
3
1
2
3
0
2
1
3
Depreciation
20
30
26
34
35
40
30
31
Profit before tax
161
178
186
230
130
278
145
296
Tax
23%
54%
27%
24%
29%
32%
17%
29%
Net Profit
124
83
136
173
93
190
120
211
EPS in Rs
2.22
1.48
2.42
3.09
1.65
3.38
2.13
3.75
ANTHEM profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
1,231
1,057
1,419
1,845
2,124
2,046
Sales growth
12
-14
34
30
15
-1
Expenses
666
626
914
1,173
1,290
1,200
Operating Profit
565
431
506
672
834
846
OPM
46%
41%
36%
36%
39%
41%
Other Income
49
139
63
85
131
144
Interest
10
9
10
11
7
6
Depreciation
58
64
82
89
134
135
Profit before tax
546
497
477
657
824
849
Tax
26%
23%
23%
31%
28%
-
Net Profit
406
385
367
451
592
614
EPS in Rs
7.11
6.75
6.57
8.07
10.54
10.91
Dividend Payout
0%
0%
0%
0%
19%
-
ANTHEM balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
112
112
112
112
113
Reserves
1,813
2,298
2,640
2,930
3,168
Borrowings
239
113
108
54
40
Other Liabilities
235
284
424
333
365
Total Liabilities
2,398
2,808
3,284
3,429
3,686
Fixed Assets
483
705
769
783
768
CWIP
345
297
263
264
309
Investments
472
433
545
1,007
1,261
Other Assets
1,099
1,373
1,707
1,374
1,348
Total Assets
2,398
2,808
3,284
3,429
3,686
ANTHEM cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
333
306
140
271
844
Cash from Investing Activity
-205
-376
-221
-147
-702
Cash from Financing Activity
181
64
-77
-136
-40
Net Cash Flow
308
-6
-158
-12
103
Free Cash Flow
307
112
-156
12
637
CFO/OP
81%
98%
51%
64%
126%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit